TipRanks
Go Ultimate55% OFF

PHC Holdings Corp. (2GY) AI Stock Analysis

DE:2GY

PHC Holdings Corp.

(Frankfurt:2GY)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Cash GenerationPHC generates substantial operating and free cash flow despite thin reported earnings, indicating healthy cash conversion from its healthcare operations. Sustained cash production can support debt service, ongoing investment, and customer support while providing resilience across the next several quarters.
Negative Factors
Near-Breakeven Net ProfitabilityVery thin net profitability shows that PHC is not consistently converting solid gross margins and positive operating earnings into durable bottom-line returns. This limits internal capital formation and leaves earnings more vulnerable to cost, financing, or operating pressures.

PHC Holdings Corp. (2GY) vs. iShares MSCI Germany ETF (EWG)

-20%0%20%40%60%80%DE:2GY+42.91%EWG+6.61%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 1.02B
Dividend Yield
2.93%
Average Volume (3M)
600
Price to Earnings (P/E)
19.5
Beta (1Y)
0.62
Revenue Growth
-6.92%
EPS Growth
-27.80%
Country
Germany
Employees
8,647
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

PHC Holdings Corp. Business Overview & Revenue Model

Company Description

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blo...

PHC Holdings Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:2GY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.42B12.22―5.97%20.88%44.61%
JP:7963JP:796364NeutralJPY 8.49B10.10―2.90%9.02%8.88%
JP:6849JP:684961NeutralJPY 265.01B19.32―1.98%1.43%1.86%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:4549JP:454950NeutralJPY 76.06B41.05―2.51%3.92%-52.01%
JP:7600JP:760047NeutralJPY 15.22B-69.06―2.94%-6.64%67.08%

* Healthcare Sector Average

Performance Comparison

0%50%100%DE:2GYJP:4549JP:6678JP:6849JP:7600JP:7963Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:2GY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:2GYPHC Holdings Corp.7.802.2540.41%
JP:4549Eiken Chemical Co., Ltd.2238.00-95.34-4.09%
JP:6678Techno Medica Co., Ltd.2161.00334.3718.31%
JP:6849Nihon Kohden Corporation1589.50-157.88-9.04%
JP:7600Japan Medical Dynamic Marketing, Inc.568.0088.5018.46%
JP:7963Koken Ltd.1705.00-118.08-6.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.